News Industry News Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia July 30, 2014
News Industry News The Medicines Company and Alnylam Announce Presentation of New Pre-Clinical Data on PCSK9 at Arteriosclerosis, Thrombosis and Vascular Biology 2014 Scientific Sessions May 01, 2014
News Industry News Sanofi and Regeneron To Present Alirocumab Clinical Data at the American College of Cardiology's 63rd Annual Scientific Session March 27, 2014
News Industry News Resverlogix Expands Phase 2b Program with the Commencement of Dosing in SUSTAIN September 27, 2011
News Industry News Johns Hopkins to Address Topics in Atrial Fibrillation, Interventional Cardiology and Lipids Live Online at CardioCareLive June 28th and 29th May 24, 2011